XueYin Xu, Lian Tang, XiangHua Piao, ShaoQing Zhan, Yong Chen, PanFeng Feng. "Economic evaluation of finotonlimab plus bevacizumab as first-line therapy for advanced hepatocellular carcinoma." PLoS ONE, 2026. doi:10.1371/journal.pone.0349044